Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Bader · SciRah

Researcher profile · Semantic Scholar

G. Bader

Share profile

G. Bader — researcher profile on SciRah

h-index: 17
Works: 66
Citations: 1,155

Most-cited papers

Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation.
S. Themistoclakis, Robert A. Schweikert, W. Saliba, A. Bonso +6 more
2008Heart Rhythm197 citations
Semantic Scholar
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
G. Rodrigo, D. Price, A. Anzueto, Dave Singh +5 more
2017International Journal of COPD143 citations Open access
Semantic Scholar
Carotid Intima Media Thickness and Plaques Can Predict the Occurrence of Ischemic Cerebrovascular Events
P. Prati, A. Tosetto, D. Vanuzzo, G. Bader +4 more
2008Stroke143 citations Open access
Semantic Scholar
Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study
M. C. Rossi, G. Lucisano, M. Comaschi, C. Coscelli +7 more
2011Diabetes Care70 citations Open access
Semantic Scholar
Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease
F. Perini, Elisabetta Galloni, I. Bolgan, G. Bader +14 more
2005Neurological Sciences54 citations
Semantic Scholar
Apolipoprotein E Polymorphism Is Not Associated with Longevity or Disability in a Sample of Italian Octo- and Nonagenarians
G. Bader, Giovanni Zuliani, G. Kostner, R. Fellin
1998Gerontology53 citations
Semantic Scholar
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
A. Anzueto, C. Vogelmeier, K. Kostikas, K. Mezzi +5 more
2017International Journal of COPD49 citations Open access
Semantic Scholar
The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes.
H. Kraft, A. Lingenhel, G. Bader, G. Kostner +1 more
1995Atherosclerosis48 citations
Semantic Scholar
Determinants of Carotid Plaque Occurrence
P. Prati, D. Vanuzzo, M. Casaroli, G. Bader +5 more
2006Cerebrovascular Diseases40 citations
Semantic Scholar
Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies
Ah-Ren Bo, C. Mathieu, G. Bader, A. Schweizer +1 more
2014Diabetologia38 citations Open access
Semantic Scholar
Determinants of carotid plaque occurrence. A long-term prospective population study: the San Daniele Project.
P. Prati, D. Vanuzzo, M. Casaroli, G. Bader +5 more
2006Cerebrovascular Diseases31 citations
Semantic Scholar
XXIV World Allergy Congress 2015
Heung-Man Lee, Ii-Ho Park, Jae-Min Shin, H. Yoon +496 more
2016The World Allergy Organization Journal30 citations Open access
Semantic Scholar
Human Lecithin:Cholesterol Acyltransferase Deficiency: In Vivo Kinetics of Low-Density Lipoprotein and Lipoprotein-X
M. Nishiwaki, K. Ikewaki, G. Bader, H. Nazih +4 more
2006Arteriosclerosis, Thrombosis and Vascular Biology27 citations Open access
Semantic Scholar
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression
F. Saliba, L. Fischer, P. de Simone, P. Bernhardt +2 more
2018Annals of Transplantation22 citations Open access
Semantic Scholar
The importance of the highest normokalemia in the treatment of early hepatic encephalopathy.
G. Zavagli, Giorgio Ricci, G. Bader, G. Mapelli +2 more
1993Mineral and Electrolyte Metabolism22 citations
Semantic Scholar
Vildagliptin more effectively achieves a composite endpoint of HbA₁c < 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment.
G. Bader, P. Geransar, A. Schweizer
2013Diabetes Research and Clinical Practice19 citations
Semantic Scholar
High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: A cross sectional study
Giovanni Zuliani, E. Palmieri, S. Volpato, G. Bader +7 more
199717 citations
Semantic Scholar
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis
M. Burnier, Shan-Yan Lin, L. Ruilope, G. Bader +2 more
2019Blood Pressure16 citations Open access
Semantic Scholar
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
C. Vogelmeier, N. Zhong, M. Humphries, K. Mezzi +4 more
2016International Journal of COPD15 citations Open access
Semantic Scholar
In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
M. Hannuksela, M. Brousseau, S. Meyn, H. Nazih +4 more
2002Atherosclerosis15 citations
Semantic Scholar
Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo- nonagenarians
G. Zuliani, G. Bader, T. Imbastaro, A. Mezzetti +4 more
1995Aging15 citations
Semantic Scholar
Demonstrating the burden of hypoglycemia on patients' quality of life in diabetes clinical trials: measurement considerations for hypoglycemia.
H. Gilet, J. Gruenberger, G. Bader, M. Viala-Danten
2012Value in Health13 citations Open access
Semantic Scholar
Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials
A. D'Urzo, G. Bader, Steven Shen, P. Goyal +1 more
2018npj Primary Care Respiratory Medicine10 citations Open access
Semantic Scholar
Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies
J. Sison, R. R. Vega, D. Hu, G. Bader +1 more
2018Current Medical Research and Opinion9 citations
Semantic Scholar
A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM
D. Matthews, P. Paldánius, M. Stumvoll, Jackie Han +4 more
2019Diabetes, obesity and metabolism8 citations Open access
Semantic Scholar
Relationship Between Duration of Type 2 Diabetes and Effectiveness of DPP-4 Inhibitor Versus Sulfonylurea as Add-on Therapy: A Post Hoc Analysis
H. Brath, P. Paldánius, G. Bader, C. Mathieu
2017Diabetes Therapy7 citations Open access
Semantic Scholar
Vascular Health and Risk Management Dovepress Effectiveness and Tolerability of Second-line Treatment with Vildagliptin versus Other Oral Drugs for Type 2 Diabetes in a Real-world Setting in the Middle East: Results from the Edge Study Feryal a Al-saber 2
C. Saab, J. Haddad, M. Khalil, Jallo +3 more
7 citations
Semantic Scholar
Benefit of statins in daily practice? A six-year retrospective observational study.
P. Deambrosis, G. Terrazzani, T. Walley, G. Bader +3 more
2009Pharmacological Research6 citations
Semantic Scholar
Evidence against the widespread use of angiography of noncoronary arteries during coronary artery angiography and cardiac catheterization.
G. Rigatelli, A. Baratto, S. Panin, E. Bedendo +2 more
2005Cardiovascular Revascularization Medicine6 citations
Semantic Scholar
Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany
R. Göke, G. Bader, M. Dworak
2014Diabetes Therapy5 citations Open access
Semantic Scholar
Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
M. Carantoni, Giovanni Zuliani, G. Bader, E. Palmieri +5 more
1999NMCD. Nutrition Metabolism and Cardiovascular Diseases5 citations
Semantic Scholar
EEG brain mapping in focal brain lesions: Normality ratio versus score
M. Matoušek, G. Bader
19903 citations
Semantic Scholar
PDB54 HRQoL and Clinical Impact of Mild Patient-Reported Hypoglycaemic Episodes in Five European Countries: Extent of Agreement Between Physician- and Patient-Reported Hypoglycaemic Episodes
J. Gruenberger, G. Bader, M. Benford, J. Pike
20112 citations Open access
Semantic Scholar
Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression
F. Saliba, L. Fischer, P. de Simone, P. Bernhardt +2 more
2019Annals of Transplantation1 citations Open access
Semantic Scholar
Indacaterol/glycopyrronium (IND/GLY) delays clinically important deterioration (CID) versus salmeterol/fluticasone (SFC) in symptomatic COPD patients: LANTERN/ILLUMINATE pooled analysis
A. Anzueto, K. Kostikas, K. Mezzi, S. Fucile +4 more
20161 citations
Semantic Scholar
Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
J. Hurst, S. Suissa, K. Rabe, G. Bader +5 more
20161 citations
Semantic Scholar
Effects of treatment withdrawal on brachial and central aortic pressure after direct renin inhibition or angiotensin receptor blockade
P. Lacy, P. Brunel, G. Bader, A. Jones +3 more
2015Journal of the Renin-Angiotensin-Aldosterone System1 citations Open access
Semantic Scholar
Omalizumab add-on therapy reduces exacerbations among responders: A pooled NNT analysis from 5 phase 3 studies
I. Kasujee, G. Bader
20141 citations
Semantic Scholar
Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study
P. Nilsson, H. Brath, A. Penfornis, J. J. de Castro +9 more
20141 citations
Semantic Scholar
[CardiReset: general medicine and monitoring of cardiovascular risk factors in a whole region].
D. Vanuzzo, F. Samani, L. Canciani, Romano Paduano +8 more
2009Giornale italiano di cardiologia1 citations
Semantic Scholar
Vascular risk factors and lipoprotein(a) levels in the differential diagnosis of dementias
G. Zuliani, A. Ble, M. R. Munari, E. Palmieri +5 more
19981 citations
Semantic Scholar
4.P.288 The metabolic basis of a new form of recessive hypercholesterolemia: The “FH-like” hypercholesterolemia
G. Zuliani, M. Arca, G. Bader, A. Pacifico +7 more
19971 citations
Semantic Scholar
High-density lipoprotein cholesterol strongly discriminates between healthy free-living and disabled octo-nonagenarians: a cross sectional study. Associazione Medica Sabin.
Giovanni Zuliani, E. Palmieri, Stefano Volpato, G. Bader +6 more
1997Aging1 citations
Semantic Scholar
Author response for "A pre‐specified statistical analysis plan for the VERIFY study: vildagliptin efficacy in combination with metformin for early treatment of T2DM"
D. R. Matthews, P. Paldánius, M. Stumvoll, Jackie Han +4 more
20190 citations
Semantic Scholar
A2519 Renoprotective effect of angiotensin receptor blockers beyond their BP lowering effect in patients with hypertension and chronic kidney disease: A systematic review and meta-analysis
M. Burnier, L. Ruilope, Shan-Yan Lin, G. Bader +3 more
2018Journal of Hypertension0 citations
Semantic Scholar
Indacaterol/Glycopyrronium (IND/GLY) verzögert eine klinisch relevante Verschlechterung im Vergleich zu Salmeterol/Fluticason (SFC) bei symptomatischen COPD Patienten: zusammenfassende Analyse der LANTERN/ILLUMINATE Studien
O. Kornmann, A. Anzueto, K. Kostikas, Karen Mezzi +5 more
2017Pneumologie0 citations
Semantic Scholar
Efetividade e segurança de vildagliptina comparativamente com outros antidiabéticos orais em doentes com diabetes tipo 2: estudo EDGE em Portugal
J. J. de Castro, M. Marcelino, J. Fernandes, C. Mathieu +1 more
20160 citations Open access
Semantic Scholar
Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) versus open-label tiotropium (Tio) in COPD patients: Post hoc analysis from SHINE and SPARK studies
A. Anzueto, K. Kostikas, K. Mezzi, S. Fucile +4 more
20160 citations
Semantic Scholar
Relationship between Diabetes Duration and Real-World Effectiveness of Second-Line Dual OAD Therapy
H. Brath, P. M. Paldanius, G. Bader, C. Mathieu
20150 citations
Semantic Scholar
Whole Brain Volume Measurements in Multiple Sclerosis: Cross-Sectional Data Comparison Between Three Methods (P6.154)
Chen-Yu Wang, H. Beadnall, S. Hatton, G. Bader +3 more
2015Neurology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Fogel×7
Invite
R. Fogel — researcher profile on SciRah
K. Kostikas×6
Invite
K. Kostikas — researcher profile on SciRah
A. Anzueto×5
Invite
A. Anzueto — researcher profile on SciRah
R. Fellin×5
Invite
R. Fellin — researcher profile on SciRah

×5

Invite

Steven Shen — researcher profile on SciRah

Invite

D. Banerji — researcher profile on SciRah

Invite

C. Mathieu — researcher profile on SciRah

Invite

D. Vanuzzo — researcher profile on SciRah

Invite

L. Canciani — researcher profile on SciRah

Giovanni Zuliani×4

Invite

Giovanni Zuliani — researcher profile on SciRah

Invite

K. Mezzi — researcher profile on SciRah

Invite

S. Fucile — researcher profile on SciRah